Conference
Comparisons Of Baseline Characteristics And Treatment Efficacy In Individuals With Refractory Or Unexplained Chronic Cough Enrolled In Phase 3 Trials Of Gefapixant
Authors
Blaiss M; Dicpinigaitis P; Birring S; McGarvey L; Morice A; Pavord I; Satia I; Smith J; La Rosa C; Li Q
Volume
149
Publisher
Elsevier
Publication Date
February 1, 2022
DOI
10.1016/j.jaci.2021.12.101
Conference proceedings
The Journal of Allergy and Clinical Immunology
Issue
2
ISSN
0091-6749